We are delighted to announce that this year the Advances in Ewing Sarcoma Research Meeting will be joining forces with the Euro Ewing Consortium Network Meeting. Both meetings will be held in Woburn House, London, UK.
Euro Ewing Consortium Network Meeting 2025:
Monday 30th June - Tuesday 1st July 2025
The Euro Ewing Consortium Network Meeting brings together health professionals, scientists and patient advocates in the field of Ewing sarcoma and gives an opportunity to hear the latest updates from across and beyond the Euro Ewing Consortium, to network with colleagues and to take part in focussed discussions on topics of current interest. Through the meetings, the Euro Ewing Consortium enables and promotes collaboration with the aim of improving survival and quality of life for patients with Ewing Sarcoma. This year we are very excited to join forces with the Advances in Ewing Sarcoma Research meeting and continue to develop the relationships between basic scientists and clinical researchers.
The meeting will take place at the Woburn House and is open to all with an active interest in ES research and we particularly encourage patients or carers affected by ES and early career researchers to attend.
Advances in Ewing Sarcoma Research 2025:
Wednesday 2nd July 2025
AESR 2025 will bring together Ewing sarcoma researchers from across the globe to share progress and identify priorities for future research, which will lead to improved outcomes for patients. The symposium will take place at the Woburn House, London, UK.
Overview of the Day:
The day will consist of a combination of keynote and short presentations, followed by group discussion and networking opportunities. The agenda for the day can be found here.
BCRT are pleased to be able to offer a number of travel bursaries to support attendance. To find out more about these bursaries and apply for support, please contact the BCRT research team at research@bcrt.org.uk
Submission of Abstracts:
Short presentations for AESR will be selected from submitted abstracts and we particularly encourage submissions from PhD and MD students, early career researchers or researchers new to the field of Ewing sarcoma.
Abstract submission should be no more than 300 words and include the Title, Aims, Methods, Results, Conclusions, and Next Steps. The word count excludes authors, affiliations, and acknowledgements.
Abstracts submission opens on the 1st January 2025 and should be emailed to BCRT's research team (research@bcrt.org.uk) by the 31st March 2025. Presenters will be confirmed by the May 2025.
Confirmed keynote speakers:
Dr. Adam Shlien
(The Hospital for Sick Children, Toronto, Canada)
Adam Shlien completed his undergraduate (Concordia University, Montreal) and PhD (University of Toronto) in Canada, followed by additional postdoctoral training at the Wellcome Trust Sanger Institute in Cambridge, supported by a H.L. Holmes Award where he designed some of the earliest integrative genomics studies, discovering the direct transcriptional consequences of somatic mutation.
He is now Senior Scientist and Lab Director in the Genetics & Genome Biology program at the Hospital for Sick Children, Toronto. He holds the Garron Family Chair in Childhood Cancer Research and is a Professor at the University of Toronto. Read more about Dr Shlien here.
Dr Alexander J. R. Bishop
(Greehey Children's Cancer Research Institute, UT Health, San Antonio, Texas, USA)
Alexander Bishop completed his undergraduate (Leicester University) and PhD (University of Oxford) studies in the UK. After undertaking additional post-doctoral training in Cancer Cell Biology and Genetics at Harvard School of Public Health, he joined the University of Texas, Health Science Center San Antonio, where he is now a full professor in the Department of Cell Systems and Anatomy at the Greehey Children's Cancer Research Institute.
He has a particular interest in identifying therapeutic opportunities to treat Ewing sarcoma. Read more about Dr Bishop here.
Organising Committee
The Advances in Ewing Sarcoma Research symposium has taken place for the last 5 years, with 2025 being our 3rd in person meeting. The meeting is growing each year, and this year looks set to be the largest meeting to date. Bone Cancer Research Trust supports the organisation of this key meeting, in collaboration with Professor Sue Burchill - The University of Leeds and Professor Thomas Grünewald - University of Heidelberg, Germany.
Key Details and Booking for the Joint Meeting:
Date of the Euro Ewing Consortium Network Meeting: Monday 30th June and Tuesday 1st July 2025
Date of the Advances in Ewing Sarcoma Research Meeting: Wednesday 2nd July 2025
Location: Woburn Hall, London, WC1H 9HQ.
Intended audience: Patient advocates and scientific and clinical community.
Registration: Free for all delegates
Travel
Arriving by car: In order to help reduce our event's carbon footprint, we strongly recommend using public transport to get to the event. There is no car parking at Woburn House. The nearest parking is on metered parking at Tavistock Square or in neighbouring streets. Local car parks can be found here.
Arriving by train: There are various trains and tubes you can use to get to the Woburn House.
If you are taking the train, Woburn House is a 5 minute walk from Euston and a 14 minute walk from King's Cross St. Pancras.
If you are taking the underground, Woburn House is a 5 minute walk from Euston underground, a 14 minute walk from Kings Cross St. Pancras underground, or a 7 minute walk from either Euston Square or Russell Square.
Arriving by aeroplane: London City Airport is 9.5 miles from Bloomsbury, where Woburn House is situated. In order to get from the airport, you can take the Docklands Light Railway (DLR) or a taxi:
- Docklands Light Railway (DLR): DLR serves London City Airport and provides fast connections to central London. Trains depart every 4 to 10 minutes.
- Taxi: There is a taxi rank with licensed London Black Taxis outside the terminal building. Fares can vary according to time of day and traffic conditions.
Donate now (This link opens in a new window) More about Ewing sarcoma